![](/img/cover-not-exists.png)
Structural Optimization Affording 2-( R )-(1-( R )-3,5-Bis(trifluoromethyl)phenylethoxy)-3-( S )-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a Potent, Orally Active, Long-Acting Morpholine Acetal Human NK-1 Receptor Antagonist
Hale, Jeffrey J., Mills, Sander G., MacCoss, Malcolm, Finke, Paul E., Cascieri, Margaret A., Sadowski, Sharon, Ber, Elzbieta, Chicchi, Gary G., Kurtz, Marc, Metzger, Joseph, Eiermann, George, Tsou, NaVolume:
41
Language:
english
Journal:
Journal of Medicinal Chemistry
DOI:
10.1021/jm980299k
Date:
November, 1998
File:
PDF, 189 KB
english, 1998